Suppr超能文献

绵羊血浆中¹³¹I标记的胰岛素样生长因子-I载体蛋白复合物清除率的改进估计值。

Improved estimates of clearance of 131I-labelled insulin-like growth factor-I carrier protein complexes from blood plasma of sheep.

作者信息

Davis S R, Hodgkinson S C, Moore L G, Gluckman P D

机构信息

Ruakura Agricultural Centre, Ministry of Agriculture & Fisheries, Hamilton, New Zealand.

出版信息

J Endocrinol. 1989 Dec;123(3):469-75. doi: 10.1677/joe.0.1230469.

Abstract

Clearance of protein-bound forms of insulin-like growth factor-I (IGF-I) from the circulation of sheep was determined using single injections of 131I-labelled ovine or [Thr59]-human IGF-I, in the 'free' form or prebound to 50 or 150 kDa plasma binding protein fractions. The half-life of circulating protein-bound forms of IGF-I was determined by size-exclusion chromatography of plasma samples taken over a 24- to 26-h experimental period. IGF-I bound to lower molecular weight binding protein(s) (approximately 50 kDa) showed a half-life of 26-40 min (mean 34 min; n = 6), while the half-life of a high molecular weight fraction (150 kDa) was considerably longer (range 398-603 min; mean 545 min; n = 8). Metabolic clearance of IGF-I following administration of free tracer ranged from 3.0 to 5.3 ml/min in sheep (n = 4) weighing 26.0-28.5 kg. Tracer distribution volume was 59 ml/kg liveweight (n = 4). Tracer degradation products were first detected in plasma 8 h after i.v. administration. No differences in stability of the purified ovine and recombinant human IGF-I tracer preparations were observed. However, a fraction of the [Thr59]-IGF-I tracer did not possess binding activity and this was associated with excretion of a greater proportion of administered radioactivity (over 22 h) in urine in animals receiving [Thr59]-IGF-I tracer (18.4-19.3%) compared with ovine IGF-I (7.1-11.0%).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

使用单次注射游离形式或预先结合到50 kDa或150 kDa血浆结合蛋白组分上的131I标记的绵羊胰岛素样生长因子-I(IGF-I)或[苏氨酸59] - 人IGF-I,测定了绵羊循环中与蛋白结合形式的IGF-I的清除率。通过在24至26小时的实验期内采集的血浆样品的尺寸排阻色谱法,测定循环中与蛋白结合形式的IGF-I的半衰期。与较低分子量结合蛋白(约50 kDa)结合的IGF-I的半衰期为26至40分钟(平均34分钟;n = 6),而高分子量组分(150 kDa)的半衰期则长得多(范围398至603分钟;平均545分钟;n = 8)。在体重26.0至28.5 kg的绵羊(n = 4)中,给予游离示踪剂后IGF-I的代谢清除率为3.0至5.3 ml/分钟。示踪剂分布体积为59 ml/kg活体重(n = 4)。静脉注射后8小时首次在血浆中检测到示踪剂降解产物。未观察到纯化的绵羊和重组人IGF-I示踪剂制剂在稳定性上的差异。然而,一部分[苏氨酸59] - IGF-I示踪剂不具有结合活性,这与接受[苏氨酸59] - IGF-I示踪剂的动物(18.4 - 19.3%)相比绵羊IGF-I(7.1 - 11.0%)在尿液中排泄更大比例的给药放射性(超过22小时)有关。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验